Tag: Sarepta Therapeutics

  • Top Morning News: TiVo Inc. (NASDAQ:TIVO), ISIS Pharmaceuticals, Inc. (NASDAQ:ISIS), Brocade Communications Systems (NASDAQ:BRCD), Sarepta Therapeutics Inc. (NASDAQ:SRPT), HEMP (OTCMKTS:HEMP)

    Analysts at Janney Montgomery Scott upped their price target on shares of TiVo (NASDAQ:TIVO) from $13.50 to $14.00 in a research report issued to clients and investors on Friday. The firm currently has a “fair value” rating on the stock. Janney Montgomery Scott’s price target indicates a potential upside of 17.35% from the stock’s previous close. TiVo Inc. (NASDAQ:TIVO) stock opened today at $12.42 and is currently trading at $12.30. The stock showed a positive weekly performance of 0.93%.

    Summer Street keeps Isis Pharmaceuticals (NASDAQ:ISIS) at Neutral following the company’s R&D event. Isis announced today positive top-line data from a Phase 2 comparator-controlled study evaluating the incidence of venous thrombolic events (VTE) in patients treated with ISIS-FXIRx undergoing total knee replacement surgery, or total knee arthroplasty (TKA). ISIS Pharmaceuticals, Inc. (NASDAQ:ISIS) stock opened at $26.10, in current trading session and currently is at $26.97, by gaining 8.09%. The 52 week range of $20.01 – $62.66. Company’s market capitalization is 3.17 billion.

    An innovative company providing fabric based networking solutions Brocade Communication Systems, Inc (NASDAQ:BRCD) announced recently that they were entering into a collaboration with VMware. This would further enhance Brocade’s potential to increase their product offerings with advanced analytical services. Brocade Communications Systems, Inc. (NASDAQ:BRCD) stock is currently trading at $8.69. The EPS of the stock is 0.68. Company’s market capitalization is 3.77 billion.

    Roth Capital began coverage on shares of Sarepta Therapeutics (NASDAQ:SRPT) in a report released on Thursday, TheFlyOnTheWall.com reports. The firm issued a buy rating and a $52.00 price objective on the stock. Sarepta Therapeutics Inc. (NASDAQ:SRPT) stock opened the session at $34.54, and now is at $35.05. The 52 week range of the Sarepta Therapeutics Inc. (NASDAQ:SRPT) stock remained $12.12 – $55.61 and the day range was $33.60 – $35.45.

    Hemp, Inc. (OTCMKTS:HEMP) announced it has committed $1,000,000 to kick-start the search for an appropriate banking partner in Colorado and to perform due diligence thereof. The allocated funds will be held in escrow while the search begins. HEMP, INC. (OTCMKTS:HEMP) stock opened today at $0.06 and is currently trading at $0.0675.